Please wait
Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Cumberland Pharmaceuticals Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit(2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |
| Fees to be paid | Equity | Common Stock, no par value | Rule 457(o) | | | | | | |
| Equity | Preferred Stock, no par value | Rule 457(o) | | | | | | |
| Other | Warrants | Rule 457(o) | | | | | | |
| Debt | Debt Securities | Rule 457(o) | | | | | | |
| Other | Units | Rule 457(o) | | | | | | |
| Unallocated (Universal) Shelf | (1) | Rule 457(o) | (1) | | $100,000,000 | 0.00014760 | $14,760 | |
| Total Offering Amounts | | $100,000,000 | | $14,760 | |
| Total Fees Previously Paid | | | | - | |
| Total Fee Offsets | | | | - | |
| Net Fee Due | | | | $14,760 | |
(1) The amount to be registered consists of up to $100,000,000 of an indeterminate amount of common stock, preferred stock, warrants, debt securities, and/or units. There are also being registered hereunder an indeterminate number of shares of common stock and preferred stock as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance, including any applicable anti-dilution provisions. Any securities registered hereunder may be sold separately or together with other securities registered hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities.
(2) The proposed maximum offering price per unit will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. of the Instructions to the Calculation of Filing Fee Tables and Related Disclosure under Item 16(b) of Form S-3.